INNODATA INC
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
**1.**Summary of Significant Accounting Policies and Estimates
Basis of Presentation- The condensed consolidated financial statements for the interim periods included herein are unaudited; however, they contain all adjustments (consisting of only normal recurring adjustments) that, in the opinion of management, are necessary to present fairly the consolidated financial position of Innodata Inc. (including its subsidiaries, the “Company”) as of September 30, 2025 and December 31, 2024, the results of its operations and comprehensive income for the three and nine months ended September 30, 2025 and 2024, cash flows for the nine months ended September 30, 2025 and 2024, and stockholders’ equity for the three and nine months ended September 30, 2025 and 2024. The results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.
Certain information and note disclosures normally included in or with financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted from these condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Unless otherwise noted, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in the notes to the consolidated financial statements for the year ended December 31, 2024.
Principles of Consolidation- The condensed consolidated financial statements include the accounts of Innodata Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates- In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates and assumptions used in the preparation of the condensed consolidated financial statements are reasonable. Actual results could differ from those estimates. Significant estimates include those related to the allowance for credit losses and allowance for billing adjustments, useful life of long-lived assets, useful life of intangible assets, impairment of goodwill and intangible assets, valuation of deferred tax assets, valuation of stock-based compensation, pension benefit plan assumptions, litigation accruals and estimated accruals for various tax exposures.
Concentration of Credit Risk - The Company maintains its cash with highly rated financial institutions, located in the United States and in foreign locations where the Company has its operations. At September 30, 2025, the Company had cash and cash equivalents of $73.9 million, of which $20.7 million was held by its foreign subsidiaries and $53.2 million was held in the United States. To the extent that such cash exceeds the maximum insurance levels, the Company is uninsured. The Company has not experienced any losses in such accounts.
Accounts Receivable - Accounts receivable is generally recorded at the invoiced amounts, net of an allowance for expected losses and allowance for billing adjustments. The Company establishes credit terms for new customers based upon management’s review of their credit information and project terms, and performs ongoing credit evaluations of its customers, adjusting credit terms when management believes appropriate based upon payment history and an assessment of the customer’s current creditworthiness.
The Company records an allowance for credit losses for estimated losses resulting from the failure of its customers to make the required payments and an allowance for billing adjustments relating to quality issues on delivered services, service penalties, discounts and price adjustments. The allowance for credit losses is based on a review of specifically identified accounts and an overall aging analysis applied to accounts pooled based on similar risk characteristics. Judgments are made with respect to the collectability of accounts receivable within each pool based on historical experience, current payment practices, and current economic trends based on our expectations over the expected life of the receivables, generally ninety days or less. Actual credit losses could differ from those estimates.
Revenue Recognition- The Company’s revenue is recognized when services are rendered or goods are delivered to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services or goods as per the agreement with the customer. In cases where there are agreements with multiple performance obligations, the Company identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the agreement at the agreement’s inception. Performance obligations that are not distinct at agreement inception are combined. For agreements with distinct performance obligations, the Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation, if any, and then evaluates how the services are performed for the customer to determine the timing of revenue recognition.
For the Digital Data Solutions segment, revenue is recognized primarily based on the quantity delivered or resources utilized in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from agreements billed on a time-and-materials basis is recognized as services are performed. Revenue from fixed-fee agreements, which is not significant to overall revenues, is recognized based on the proportional performance method of accounting, as services are performed, or milestones are achieved.
For the Synodex segment, revenue is recognized primarily based on the quantity delivered in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from such services is recognized monthly when all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; access to the service is provided to the end user; and collection is probable.
The Agility segment derives its revenue primarily from subscription arrangements and provision of enriched media analysis services. It also derives revenue as a reseller of corporate communication solutions. Revenue from subscriptions is recognized monthly when access to the service is provided to the end user; all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; and collection is probable. Revenue from enriched media analysis services is recognized when the services are performed, and performance conditions are satisfied. Revenue from reseller agreements is recognized at the gross amount received for the goods in accordance with the Company functioning as a principal due to the Company meeting the following criteria: the Company acts as the primary obligor in the sales transaction; assumes the credit risk; sets the price; can select suppliers; and is involved in the execution of the services, including after sales service.
Revenue includes reimbursement of out-of-pocket expenses, with the corresponding out-of-pocket expenses included in direct operating costs.
Revenue associated with the services provided in one period and billed in a subsequent period is commonly referred to as unbilled revenues and is included under Accounts receivable.
The Company considers U.S. GAAP criteria for determining whether to report gross revenue as a principal versus net revenue as an agent. The Company evaluates whether it is in control of the services before the same are transferred to the customer to assess whether it is principal or agent in the arrangement.
Contract acquisition costs, which are included in prepaid expenses and other current assets, are amortized over the term of a subscription agreement or contract that normally has a duration of 12 months or less. The Company reviews these prepaid acquisition costs on a periodic basis to determine the need to adjust the carrying values for early terminated contracts. Included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets are contract acquisition costs amounting to$1.0 million and$1.1 million as of September 30, 2025 and December 31, 2024, respectively. These acquisition costs relate to our Agility segment and are amortized over the term of the subscription agreement.
Foreign Currency Translation- The functional currency of the Company’s subsidiaries in the Philippines, India, Sri Lanka, Israel, Hong Kong, the United Kingdom and Canada (other than the Agility subsidiaries) is the U.S. dollar. Transactions denominated in Philippine pesos, Indian and Sri Lankan rupees, Israeli shekels, United Kingdom Pound Sterling and Canadian dollars are translated to U.S. dollars at rates which approximate those in effect on the transaction dates. Monetary assets and all liabilities denominated in foreign currencies on September 30, 2025 and December 31, 2024 are translated at the exchange rate in effect as of those dates. Non-monetary assets and stockholders’ equity are translated at the appropriate historical rates. Included in direct operating costs were foreign exchange (gains) losses resulting from such transactions of approximately $(0.3) million and $0.5 million for the three months ended September 30, 2025 and 2024, and $0.1 million and $0.2 million for the nine months ended September 30, 2025 and 2024, respectively.
The functional currency for the Company’s subsidiary in Germany is the Euro. The functional currencies for the Company’s Agility subsidiaries in the United Kingdom and Canada are the Pound Sterling and the Canadian dollar, respectively. The financial statements of these subsidiaries are prepared in their respective currencies. Financial information is translated from the applicable functional currency to the U.S. dollar (the reporting currency) for inclusion in the Company’s condensed consolidated financial statements. Income, expenses, and cash flows are translated at weighted-average exchange rates prevailing during the fiscal period, and assets and liabilities are translated at fiscal period-end exchange rates. Resulting translation adjustments are included as a component of accumulated other comprehensive income or loss in stockholders’ equity. Foreign exchange transaction gains or losses are included in direct operating costs in the accompanying condensed consolidated statements of operations and comprehensive income (loss).
**Derivative Instruments -**The Company accounts for derivative transactions in accordance with the FASB’s Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded in other comprehensive income (loss). When the amounts recorded in other comprehensive income (loss) are reclassified to earnings, they are included as part of direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of direct operating costs.
**Capitalized Developed Software -**The Company incurs development costs related to software it develops for its internal use. Qualifying costs incurred during the application development stage are capitalized. These costs primarily consist of internal labor and third-party development costs and are amortized using the straight-line method over the estimated useful life of the capitalized developed software, which generally ranges from three toten years. All other research and maintenance costs are expensed as incurred. Capitalized developed software in progress was $3.6 million for each of the periods ended September 30, 2025 and December 31, 2024. The cumulative completed capitalized developed software was$22.5 million and$19.8 million as of September 30, 2025 and December 31, 2024, respectively.
**Income Taxes -**Estimated deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates, as well as any net operating loss or tax credit carryforwards expected to reduce taxes payable in future years. A valuation allowance is provided when it is more likely than not that all or some portion of the estimated deferred tax assets will not be realized. While the Company considers future taxable income in assessing the need for the valuation allowance, in the event that the Company anticipates that it will be able to realize the estimated deferred tax assets in the future in excess of its net recorded amount, an adjustment to the provision for deferred tax assets would increase income in the period such determination was made. Similarly, in the event that the Company anticipates that it will not be able to realize the estimated deferred tax assets in the future considering future taxable income, an adjustment to the provision for deferred tax assets would decrease income in the period such determination was made. Changes in the valuation allowance from period to period are included in the Company’s tax provision in the period of change. The Company indefinitely reinvests the foreign earnings in its foreign subsidiaries. If such earnings are repatriated in the future, or are no longer deemed to be indefinitely reinvested, the Company would have to accrue as a liability the applicable amount of foreign jurisdiction withholding taxes associated with such remittances.
In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the deferred tax assets of subsidiaries in Canada and Germany will be realizable or not.
The Company performed an assessment for one of its Canadian subsidiaries as of March 31, 2025 and the assessment yielded positive evidence enabling the release of the valuation allowance for the Canadian deferred tax assets of the subsidiary under “ASC Topic 740-30-22 – Accounting for Income Taxes”.
The Company performed an assessment for its German subsidiary as of June 30, 2025 and the assessment yielded positive evidence enabling the release of the valuation allowance for the German deferred tax assets of the subsidiary under “ASC Topic 740 - 30 - 22 - Accounting for Income Taxes”.
As the expectation of future taxable income of the second Canadian subsidiary cannot be predicted with reasonable accuracy, the Company continues to maintain a valuation allowance against the deferred tax assets of this subsidiary.
The Company accounts for income taxes regarding uncertain tax positions and recognizes interest and penalties related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations and comprehensive income.
**Deferred Revenue -**Deferred revenue represents payments received from customers in advance of providing services and amounts deferred if conditions for revenue recognition have not been met. The Company expects to recognize substantially all of these performance obligations over the next 12 months. The table below summarizes the deferred revenue balances as of September 30, 2025 and December 31, 2024 (in thousands):
| · · · · · · | ||||
|---|---|---|---|---|
| · September 30, · December 31, | ||||
| | | 2025 | | 2024 |
| Deferred revenues | | $7,025 | | $8,010 |
The table below provides information about contract liabilities (deferred revenue) and the changes in the balances for the three and nine months ended as of September 30, 2025 and 2024 were as follows (in thousands):
| · · · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · Three Months Ended · Nine Months Ended | |||||||||
| · · September 30, · · September 30, | |||||||||
| · · 2025 · 2024 · 2025 · 2024 | |||||||||
| Balance at the beginning of period | | $6,485 | | $4,770 | | $8,010 | | $3,523 | |
| Net deferred revenue in the period | | 8,481 | | | 9,673 | | 21,056 | | 24,989 |
| Revenue recognized | | (7,439) | | | (8,151) | | (22,047) | | (22,108) |
| Currency translations and other adjustments | | (502) | | | 208 | | 6 | | 96 |
| Balance at the end of period | | $7,025 | | $6,500 | | $7,025 | | $6,500 | |
Recently Issued Accounting Pronouncements Not Yet Adopted - On December 14, 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”. The effective date of this ASU is for fiscal years beginning after December 15, 2024 and interim periods beginning after December 15, 2025. The adoption of ASU 2023-09 will enhance quantitative and qualitative disclosures related to rate reconciliation of significant components and income tax paid. The Company does not anticipate any material impact from the adoption of this new standard.
In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), fourth amendment via ASU 2025-01: Disaggregation of Income Statement Expenses”. ASU No. 2024-03 does not change or remove existing expense disclosure requirements but requires disaggregated disclosures about certain expense categories and captions, including but not limited to, purchases of inventory, employee compensation, depreciation, amortization and selling expenses. ASU No. 2024-03 will be effective for the Company beginning in fiscal year 2027, and for interim financial reporting beginning in the first quarter of fiscal year 2028. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on the Company’s disclosures within the consolidated financial statements.
In July 2025, the FASB issued ASU 2025 - 05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets.” ASU 2025 - 05 provides entities with a practical expedient related to developing reasonable and supportable forecasts as part of estimating expected credit losses, in which entities may elect to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU No. 2025 - 05 will be effective for the Company beginning in fiscal year 2027. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on the Company’s disclosures within the consolidated financial statements.
In September 2025, the FASB issued ASU 2025 - 06, Intangibles - Goodwill and Other - Internal - Use Software (Subtopic 350 - 40): Targeted Improvements to the Accounting for Internal - Use Software. ASU 2025 - 06 modernizes the accounting for internal - use software costs by increasing the operability of the recognition guidance considering different methods of software development. ASU 2025 - 06, which can be applied prospectively, retrospectively, or with a modified transition approach, is effective for the Company for annual reporting as well as interim period reporting beginning in fiscal year 2029. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on the Company’s disclosures within the consolidated financial statements.
**2.**Accounts Receivable
Accounts receivable consists of the following (in thousands):
| | | | | | | |
|---|---|---|---|---|---|---|
| · September 30, · December 31, | ||||||
| · · 2025 · · 2024 | ||||||
| Gross Accounts receivable | | $41,635 | | $29,772 | ||
| Allowance for credit losses | | (1,182) | | (1,256) | ||
| Allowance for billing adjustments | | | (976) | | | (503) |
| Allowance for volume discounts | | | (37) | | | - |
| Accounts receivable, net | | $39,440 | | $28,013 | ||
Activity in the allowance for the credit losses for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands):
| · · · · · · · · · · · · | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| · Three Months Ended · Nine Months Ended | |||||||||||
| · · September 30, · · September 30, | |||||||||||
| · · 2025 · 2024 · · 2025 · 2024 | |||||||||||
| Balance at beginning of period | | $1,274 | | $1,081 | | $1,256 | | $992 | |||
| Additions charged to expense | | | 31 | | | (18) | | | 110 | | 88 |
| Write-offs against allowance | | | (118) | | | (128) | | | (189) | | (145) |
| Foreign currency translation adjustment | | | (5) | | | 7 | | | 5 | | 7 |
| Balance at end of period | | $1,182 | | $942 | | $1,182 | | $942 | |||
**3.**Goodwill and Intangible Assets
Goodwill
As of September 30, 2025, the Company performed its annual goodwill impairment analysis on one of its reporting units, the Agility segment. It involved a quantitative goodwill impairment test and estimated the fair value based on a combination of the income approach (estimates of future discounted cash flows) and the market approach (market multiples for similar companies) using unobservable inputs (Level 3). The income approach uses a discounted cash flow (“DCF”) method that utilizes the present value of cash flows to estimate the segment’s fair value. The future cash flows of the segment were projected based on the Company’s estimates of future revenues, operating income, and other factors such as working capital and capital expenditures. As part of the DCF analysis, the Company projected revenue and operating profits and assumed long - term revenue growth rates in the terminal year. The market approach utilizes multiples of revenues and earnings before interest expense, taxes, depreciation, and amortization (“EBITDA”) to estimate the segment’s fair value. The market multiples used for the segment were based on a group of comparable companies’ market multiples applied to the Company’s revenue. The Company concluded that there isno impairment of goodwill.
The change in the carrying amount of goodwill for the nine months ended September 30, 2025 was as follows (in thousands):
| · · · | ||
|---|---|---|
| Balance - January 1, 2025 | | $1,998 |
| Foreign currency translation adjustment | | 69 |
| Balance - September 30, 2025 | | $2,067 |
The fair value measurement of goodwill of the Agility segment was conducted on September 30, 2025 and was classified within Level 3 of the fair value hierarchy because the Company used the income approach, which utilizes significant inputs that are unobservable in the market and the market multiple approach using comparable entities to further validate the carrying values. The Company believes it made reasonable estimates and assumptions to calculate the fair value of the reporting unit as of the impairment test measurement date. The carrying value of Goodwill was $2.1 million and $2.0 million for the periods ended September 30, 2025 and December 31, 2024.
Intangibles
Information regarding the Company acquired intangible assets and capitalized developed software was as follows (in thousands):
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · September 30, 2025 | ||||||||||||
| · · Gross · · · · · Foreign Currency · · Net | ||||||||||||
| · · Carrying · · Accumulated · · Translation · · Carrying | ||||||||||||
| | Value | Amortization | Adjustment | Value | ||||||||
| Acquired Intangible Assets | | | | | | | | | | | | |
| Developed technology | | $2,881 | | $(2,810) | | $3 | | $74 | ||||
| Customer relationships | | 1,965 | | (1,832) | | 8 | | 141 | ||||
| Trademarks and tradenames | | 840 | | (828) | | 1 | | 13 | ||||
| Patents | | 40 | | (40) | | - | | - | ||||
| Media Contact Database | | | 3,528 | | | (3,268) | | | 16 | | | 276 |
| Total Acquired Intangible Assets | | $9,254 | | $(8,778) | | $28 | | $504 | ||||
| | | | | | | | | | | | | |
| Capitalized Developed Software | | | | | | | | | ||||
| Capitalized Developed Software | | $22,493 | | $(12,849) | | $177 | | $9,821 | ||||
| Capitalized Developed Software - in Progress | | 3,553 | | - | | 7 | | 3,560 | ||||
| Total Capitalized Developed Software | | $26,046 | | $(12,849) | | $184 | | $13,381 | ||||
| | | | | | | | | | | | | |
| Total | | $35,300 | | $(21,627) | | $212 | | $13,885 | ||||
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · December 31, 2024 | ||||||||||||
| · · Gross · · · · · Foreign Currency · · Net | ||||||||||||
| · Carrying · Accumulated · Translation · · Carrying | ||||||||||||
| · Value · Amortization · Adjustment · Value | ||||||||||||
| Acquired Intangible Assets · · · · | ||||||||||||
| Developed technology | | $3,060 | | $(2,911) | | $(3) | | $146 | ||||
| Customer relationships | | | 2,144 | | | (1,856) | | | (29) | | | 259 |
| Trademarks and tradenames | | | 862 | | | (826) | | | - | | | 36 |
| Patents | | 44 | | (44) | | | - | | | - | ||
| Media Contact Database | | | 3,546 | | | (3,016) | | | (1) | | | 529 |
| Total Acquired Intangible Assets | | $9,656 | | $(8,653) | | $(33) | | $970 | ||||
| | | | | | | | | | | | | |
| Capitalized Developed Software | | | | | | | | | | | | |
| Capitalized Developed Software | | $19,811 | | $(10,507) | | $(463) | | $8,841 | ||||
| Capitalized Developed Software - in Progress | | | 3,552 | | | - | | | (10) | | | 3,542 |
| Total Capitalized Developed Software | | $23,363 | | $(10,507) | | $(473) | | $12,383 | ||||
| | | | | | | | | | | | | |
| Total | | $33,019 | | $(19,160) | | $(506) | | $13,353 | ||||
Amortization expense relating to acquired intangible assets was $0.2 million for each of the three-month periods ended September 30, 2025 and 2024. Amortization expense relating to acquired intangible assets was $0.6 million for each of the nine-month periods ended September 30, 2025 and 2024.
Amortization expense relating to capitalized developed software was $1.0 million for each of the three-month periods ended September 30, 2025 and 2024. Amortization expense relating to capitalized developed software was $2.9 million and $2.5 million for the nine months ended September 30, 2025 and 2024, respectively.
As of September 30, 2025, estimated future amortization expense for intangible assets was as follows (in thousands):
| | | | |
|---|---|---|---|
| Year · Amortization | |||
| Remaining for 2025 | | $1,575 | |
| 2026 | | | 5,359 |
| 2027 | | | 3,895 |
| 2028 | | | 2,298 |
| 2029 | | | 516 |
| Thereafter | | | 242 |
| | | $13,885 | |
**4.**Income Taxes
For the nine months ended September 30, 2025, the Company recorded an income tax provision of approximately $6.7 million. The provision primarily reflects Federal and State income tax expense on U.S. operations, the tax impact of IRS section 162(m) adjustments, deemed interest provision, and income tax expense attributable to the Company’s subsidiaries in foreign jurisdictions in accordance with applicable local tax regulations. The tax provision was partially offset by the favorable effect of stock-based compensation, the favorable impact of withholding taxes and the release of valuation allowances on deferred tax assets of one of the Company’s Canadian and the Company’s German subsidiary, resulting from improved expectations of future taxable income in those jurisdictions.
Although the Company generated taxable income in the United States during the period, the related current tax liability waspartially offset by the utilization of deferred tax assets arising from the net operating loss carryforwards (“NOLCOs”).
The estimated effective tax rate applied to the nine-month period ended September 30, 2025 is higher than the U.S. federal statutory rate of 21% principally due to IRS section 162(m) adjustments, state income tax provisions, deemed interest and tax effect of foreign operations offset in part by the favorable effect of stock-based compensation, withholding taxes and a change in the valuation allowance.
The estimated annual effective tax rate applied to the nine-month period ended September 30, 2024 differs from the U.S. federal statutory rate of 21% principally due to the release of the U.S. valuation allowance, state income taxes and provision on uncertain tax positions.
The Company determined on March 31, 2025 that it was more likely than not that one of the Company’s subsidiaries in Canada would be able to realize the benefit of the deferred tax assets in Canada, resulting in the release of the valuation allowance. In reaching this determination, the Company considered the growing trend of profitability over the last three years in the Canadian subsidiary, as well as expectations regarding the generation of future taxable income.
The Company determined on June 30, 2025 that it was more likely than not that the Company’s subsidiary in Germany would be able to realize the benefit of the deferred tax assets in Germany, resulting in the release of the valuation allowance. In reaching this determination, the Company considered the growing trend of profitability over the last three years in the German subsidiary, as well as expectations regarding the generation of future taxable income.
Impact of Recent Tax Legislation
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted, amending U.S. tax law in several areas, including domestic research and development deductibility and bonus depreciation. The Company has included the estimated effect of provisions relevant to the current quarter in its reported income tax expense for the three months ending September 30, 2025. Management is continuing to evaluate the OBBBA’s potential impact on future periods, particularly with respect to deferred tax assets and liabilities, the effective tax rate, and cash tax obligations. The Company will update its assessment as additional interpretive guidance or implementing regulations are issued.
The reconciliations of the U.S. federal statutory rate with the Company’s effective tax rate for the nine months ended September 30, 2025 and 2024, respectively, are summarized in the table below:
| | | | | | |
|---|---|---|---|---|---|
| · · For the Nine Months · | |||||
| · · Ended September 30, · | |||||
| · 2025 · 2024 · | |||||
| Federal income tax expense at statutory rate | 21.0% | 21.0% | |||
| Effect of: | | | | | |
| Section 162 (m) | | 9.3 | | - | |
| State income tax net of federal benefit | | 2.9 | | (4.5) | |
| Deemed interest | | 2.8 | | (0.9) | |
| Tax effects of foreign operations | | 1.0 | | 0.8 | |
| Foreign operations permanent differences - foreign exchange gains and losses | | 0.5 | | 0.3 | |
| GILTI provisions | | 0.4 | | 2.8 | |
| Change in unrecognized tax benefits (ASC 740) | | 0.3 | | (3.1) | |
| Return to provision true up | | - | | (1.4) | |
| Change in tax rates | | (0.4) | | - | |
| Foreign rate differential | | (0.4) | | (0.7) | |
| Change in valuation allowance | | (1.2) | | (54.6) | |
| Withholding tax | | (2.1) | | 0.8 | |
| Effect of stock-based compensation | | (11.5) | | (0.4) | |
| Other | | (0.3) | | 0.1 | |
| Effective tax rate | | 22.3% | (39.8)% | ||
The following table presents a roll-forward of the Company’s unrecognized tax benefits and associated interest for the nine months ended September 30, 2025 (in thousands):
| | | | |
|---|---|---|---|
| | Unrecognized | ||
| | Tax Benefits | ||
| Balance - January 1, 2025 | | $999 | |
| Increase for current period tax positions | | 250 | |
| Decrease for prior year tax positions | | | (214) |
| Interest accrual | | 44 | |
| Foreign currency remeasurement | | (27) | |
| Balance - September 30, 2025 | | $1,052 | |
**5.**Operating Leases
The Company has various lease agreements for its offices and service delivery centers and has determined that the risks and benefits related to these leased properties are retained by the lessors. Accordingly, these are accounted for as operating leases. Lease agreements with a term of less than one year are treated as short-term leases and are accounted for separately as shown in the table below.
Most of these lease agreements are renewable at the mutual consent of the parties to the contract. These lease agreements are for terms ranging fromtwo toeleven years and, in most cases, provide for rent escalations ranging from 1.75% to 15%.
The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases for the periods presented (in thousands):
| · · · · · · · · · · · · | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| · · For the Three Months Ended · · For the Nine Months Ended | ||||||||||
| · · September 30, · · September 30, | ||||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||||
| Rent expense for long-term operating leases | | $337 | | $314 | | $966 | | $943 | ||
| Rent expense for short-term leases | | 46 | | 51 | | | 136 | | | 142 |
| Total rent expense | | $383 | | $365 | | $1,102 | | $1,085 | ||
The following table presents the maturity profile of the Company’s operating lease liabilities based on the contractual undiscounted payments with a reconciliation of these amounts to the remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet as of September 30, 2025 (in thousands):
| · · · | ||
|---|---|---|
| Year · Amount | ||
| Remaining for 2025 | | $368 |
| 2026 | | 1,562 |
| 2027 | | 1,560 |
| 2028 | | 1,159 |
| 2029 | | 722 |
| 2030 and thereafter | | 194 |
| Total lease payments | | 5,565 |
| Less: Interest | | (888) |
| Net present value of lease liabilities | | $4,677 |
| | | |
| Current portion | | $1,122 |
| Long-term portion | | 3,555 |
| Total | | $4,677 |
The weighted average remaining lease terms and discount rates for all of the Company’s operating leases as of September 30, 2025 were as follows:
| · · · | |
|---|---|
| Weighted-average lease term remaining · 41 months · | |
| Weighted-average discount rate | 9.16% |
**6.**Long-term obligations
Total long-term obligations as of September 30, 2025 and December 31, 2024 consisted of the following (in thousands):
| | | | | | | |
|---|---|---|---|---|---|---|
| · September 30, · December 31, | ||||||
| · 2025 · 2024 | ||||||
| Pension obligations - accrued pension liability | | $8,670 | | $7,945 | ||
| Microsoft licenses (1) | | 111 | | 442 | ||
| | | | 8,781 | | | 8,387 |
| Less: Current portion of long-term obligations | | 1,221 | | 1,643 | ||
| Total Non-Current portion of long-term obligations | | $7,560 | | $6,744 | ||
(1)In March 2023, the Company renewed a vendor agreement to acquire certain additional software licenses, receive technical support and future software upgrades on software licenses through February 2026. Pursuant to this agreement, the Company is contractually liable to pay approximately $0.4 million annually over the term of the agreement.
**7.**Commitments and Contingencies
**Litigation –**In 2008, a judgment was rendered in the Philippines against a Philippine subsidiary of the Company that is no longer active and purportedly also against Innodata Inc., in favor of certain former employees of the Philippine subsidiary. The potential payment amount aggregates to approximately$5.6 million, plus legal interest that accrued at 12% per annum from August 13, 2008 to June 30, 2013, and thereafter accrued and continues to accrue legal interest at 6% per annum. The potential payment amount as expressed in U.S. dollars varies with the Philippine peso to U.S. dollar exchange rate. In December 2017, a group of 97 of the former employees of the Philippine subsidiary indicated that they proposed to record the judgment as to themselves in New Jersey. In January 2018, in response to an action initiated by Innodata Inc., the United States District Court for the District of New Jersey (“USDC”) entered a preliminary injunction that enjoins these former employees from pursuing or seeking recognition or enforcement of the judgment against Innodata Inc. in the United States during the pendency of the action and until further order of the USDC. In June 2018, the USDC entered a consent order administratively closing the action subject to return of the action to the active docket upon the written request of Innodata Inc. or the former employees, with the USDC retaining jurisdiction over the matter and the preliminary injunction remaining in full force and effect.
In February 2024, David D’Agostino filed a putative class action captioned D’Agostino v. Innodata Inc., et al., in the United States District Court for the District of New Jersey against the Company and certain of its current and former officers (the “Securities Class Action”). In October 2024, the presiding judge in the Securities Class Action appointed a lead plaintiff and approved the lead plaintiff’s choice of counsel. The Securities Class Action complaint, as amended, asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, and it alleges, among other things, that the defendants made false and misleading statements regarding the Company’s artificial intelligence (“AI”) technology and services. The plaintiff seeks unspecified damages, fees, interest, and costs. The Company intends to defend itself vigorously. On March 7, 2025, the Company filed a motion to dismiss the Securities Class Action complaint. On April 10, 2025, the plaintiff filed a Second Amended Complaint to the Securities Class Action complaint (the “Second Amended Complaint”) to correct purported typographical errors in the Securities Class Action complaint. On April 11, 2025, the Company filed a motion to dismiss the Second Amended Complaint. The motion to dismiss is fully briefed and pending with the USDC. The Company cannot predict the outcome of the action at this time and can give no assurance that the asserted claims will not have a material adverse effect on its financial position or results of operations.
The Company is also subject to various other legal proceedings and claims that have arisen in the ordinary course of business. While the Company believes that it has adequate reserves for those losses that it believes are probable and can be reasonably estimated, the ultimate results of legal proceedings and claims cannot be predicted with certainty.
While management currently believes that the ultimate outcome of these proceedings will not have a material adverse effect on the Company’s consolidated financial position or overall trends in consolidated results of operations, litigation is subject to inherent uncertainties. Substantial recovery against the Company in the above-referenced Philippine action could have a material adverse impact on the Company, and unfavorable rulings or recoveries in the other proceedings described above could have a material adverse impact on the consolidated operating results in the period in which the ruling or recovery occurs. In addition, the Company’s estimate of the potential impact on the Company’s consolidated financial position or overall consolidated results of operations for the above referenced legal proceedings could change in the future.
The Company’s legal accruals related to legal proceedings and claims are based on the Company’s determination of whether or not a loss is probable. The Company reviews outstanding proceedings and claims with external counsel to assess probability and estimates of loss. The accruals are adjusted if necessary. While the Company intends to defend these matters vigorously, adverse outcomes that it estimates could reach approximately $500,000 in the aggregate beyond recorded amounts are reasonably possible. If circumstances change, the Company may be required to record adjustments that could be material to its reported consolidated financial condition and results of operations.
**8.**Stock Options and Restricted Stock Units
The stock-based compensation expense related to the Innodata Inc. 2013 Stock Plan, as amended and restated effective June 7, 2016 (the “2013 Plan”) and the Innodata Inc. 2021 Equity Compensation Plan, as amended and restated effective as of April 11, 2022 (the “2021 Plan”, and together with the 2013 Plan, collectively, the “Equity Plans”) were allocated as follows (in thousands):
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · For the Three Months Ended · · For the Nine Months Ended | ||||||||
| · · September 30, · · September 30, | ||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||
| Direct operating costs | | $444 | | $43 | | $1,312 | | $200 |
| Selling and administrative expenses | | 2,263 | | 812 | | 6,997 | | 2,681 |
| Total stock-based compensation | | $2,707 | | $855 | | $8,309 | | $2,881 |
Stock Options
2013 Plan
A summary of option activity under the 2013 Plan and changes during each of the nine-month periods ended September 30, 2025 and 2024 are presented below:
| · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · · Weighted-Average · | ||||||||
| · · · Weighted - Average · Remaining Contractual · · Aggregate | ||||||||
| · Number of Options · Exercise Price · Term (years) · Intrinsic Value | ||||||||
| Outstanding at January 1, 2025 | 3,165,193 | | $3.67 | 6.32 | $113,458,326 | |||
| Granted | - | | - | - | | - | ||
| Exercised | (246,742) | | 4.57 | - | | - | ||
| Forfeited/Expired | - | | - | - | | - | ||
| Outstanding at September 30, 2025 | 2,918,451 | | $3.60 | 5.60 | | $214,423,447 | ||
| | | | | | | | ||
| Exercisable at September 30, 2025 | 2,820,116 | | $3.60 | | 5.55 | | $207,180,091 | |
| | | | | | | | ||
| Vested and Expected to vest at September 30, 2025 | 2,918,451 | | $3.60 | 5.60 | | $214,423,447 | ||
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · · · Weighted-Average · · | ||||||||||
| · · · · Weighted - Average · · Remaining Contractual · · Aggregate | ||||||||||
| · · Number of Options · · Exercise Price · · Term (years) · · Intrinsic Value | ||||||||||
| Outstanding at January 1, 2024 | | 5,339,162 | | $3.22 | | 6.38 | | $28,640,009 | ||
| Granted | - | | - | - | | - | ||||
| Exercised | (159,232) | | 4.07 | - | | - | ||||
| Forfeited/Expired | (4,001) | | 6.96 | - | | - | ||||
| Outstanding at September 30, 2024 | 5,175,929 | | $3.19 | 5.62 | | $70,306,343 | ||||
| | | | | | | | | | | |
| Exercisable at September 30, 2024 | 3,586,369 | | $2.45 | 4.78 | | $51,361,592 | ||||
| | | | | | | | | | | |
| Vested and Expected to vest at September 30, 2024 | 5,175,929 | | $3.19 | 5.62 | | $70,306,343 | ||||
2021 Plan
A summary of option activity under the 2021 Plan and changes during the nine-month periods ended September 30, 2025 and 2024 are presented below.
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · Weighted-Average · · | ||||||||||
| · · · · Weighted - Average · · Remaining Contractual · · Aggregate | ||||||||||
| · Number of Options · Exercise Price · Term (years) · Intrinsic Value | ||||||||||
| Outstanding at January 1, 2025 | 842,271 | | $15.86 | 8.46 | $20,847,471 | |||||
| Granted | - | | - | - | | - | ||||
| Exercised | (119,739) | | 3.51 | - | | - | ||||
| Forfeited/Expired | (22,668) | | 3.41 | - | | - | ||||
| Outstanding at September 30, 2025 | 699,864 | | $18.38 | 7.85 | | $41,075,152 | ||||
| | | | | | | | | | | |
| Exercisable at September 30, 2025 | 194,006 | | $3.32 | 6.98 | | $14,308,582 | ||||
| | | | | | | | | | | |
| Vested and Expected to vest at September 30, 2025 | 699,864 | | $18.38 | 7.85 | | $41,075,152 | ||||
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · · · Weighted-Average · · | ||||||||||
| · · · · Weighted - Average · · Remaining Contractual · · Aggregate | ||||||||||
| · · Number of Options · · Exercise Price · · Term (years) · · Intrinsic Value | ||||||||||
| Outstanding at January 1, 2024 | 923,571 | | $3.41 | | 8.76 | $4,786,252 | ||||
| Granted | - | | - | | - | | - | |||
| Exercised | (47,596) | | 3.41 | | - | | - | |||
| Forfeited/Expired | (9,668) | | 5.40 | | - | | - | |||
| Outstanding at September 30, 2024 | 866,307 | | $3.39 | | 8.01 | | $11,591,122 | |||
| | | | | | | | | | | |
| Exercisable at September 30, 2024 | 339,613 | | $3.36 | | 7.99 | | $4,554,490 | |||
| | | | | | | | | | | |
| Vested and Expected to vest at September 30, 2024 | 866,307 | | $3.39 | | 8.01 | | $11,591,122 | |||
There wereno options granted during the nine months ended September 30, 2025 and 2024.
During the nine months ended September 30, 2025, a total of 366,481 options were exercised at an average exercise price of $4.22.
The compensation cost related to non-vested stock options not yet recognized as of September 30, 2025 totaled approximately$6.4 million. The weighted-average period over which these costs will be recognized is 27 months.
Restricted Stock Units
Restricted stock unit activity under the Equity Plans during each of the nine-month periods ended September 30, 2025 and 2024 are presented below:
| | | | | | |
|---|---|---|---|---|---|
| · · · Weighted-Average | |||||
| · · Number of · · Grant Date | |||||
| · Restricted Stock Units · Fair Value | |||||
| Unvested at January 1, 2025 | | 1,249,079 | | $20.98 | |
| Granted | 39,049 | | 54.12 | ||
| Vested | (214,506) | | 6.43 | ||
| Forfeited/Expired | (555,208) | | 7.97 | ||
| Unvested at September 30, 2025 | 518,414 | | $43.44 | ||
| · · · · · | |||
|---|---|---|---|
| · · Weighted-Average | |||
| · · Number of · · Grant Date | |||
| · · Restricted Stock Units · · Fair Value | |||
| Unvested at January 1, 2024 | 749,756 | | $5.77 |
| Granted | 28,973 | | 15.10 |
| Vested | (48,761) | | 8.42 |
| Forfeited/Expired | (995) | | 8.29 |
| Unvested at September 30, 2024 | 728,973 | | $5.96 |
A total of 11,829 restricted stock units were granted to non-employee directors during the nine months ended September 30, 2025.
The compensation cost related to non-vested restricted stock units not yet recognized as of September 30, 2025 totaled approximately$17.0 million. The weighted-average period over which these costs will be recognized is 26 months.
**9.**Comprehensive loss
Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, consists of pension liability adjustments, net of taxes, foreign currency translation adjustment and changes in fair value of derivatives, net of taxes. The components of accumulated other comprehensive loss as of September 30, 2025 and 2024, and reclassifications from accumulated other comprehensive loss for the threeand nine-month periods, are presented below (in thousands):
| · · · · · · · · · · · · | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| · Pension · · · Foreign Currency · | |||||||||||
| · Liability · Fair Value of · Translation · Accumulated Other | |||||||||||
| · Adjustment · Derivatives · Adjustment · Comprehensive Loss | |||||||||||
| Balance at July 1, 2025 | | $(269) | | $127 | | $(1,151) | | $(1,293) | |||
| Other comprehensive loss before reclassifications, net of taxes | | | - | | (378) | | (178) | | (556) | ||
| Total other comprehensive loss before reclassifications, net of taxes | | | (269) | | (251) | | (1,329) | | (1,849) | ||
| Net amount reclassified to earnings | | | (1) | | 63 | | - | | 62 | ||
| Balance at September 30, 2025 | | $(270) | | $(188) | | $(1,329) | | $(1,787) | |||
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · Pension · · · Foreign Currency · | ||||||||
| · Liability · Fair Value of · Translation · Accumulated Other | ||||||||
| · Adjustment · Derivatives · Adjustment · Comprehensive Loss | ||||||||
| Balance at January 1, 2025 | | $(233) | | $(395) | | $(1,842) | | $(2,470) |
| Other comprehensive income (loss) before reclassifications, net of taxes | (37) | | 8 | | 513 | | 484 | |
| Total other comprehensive loss before reclassifications, net of taxes | (270) | | (387) | | (1,329) | | (1,986) | |
| Net amount reclassified to earnings | - | | 199 | | - | | 199 | |
| Balance at September 30, 2025 | | $(270) | | $(188) | | $(1,329) | | $(1,787) |
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · Pension · · · Foreign Currency · | ||||||||
| · Liability · Fair Value of · Translation · Accumulated Other | ||||||||
| · Adjustment · Derivatives · Adjustment · Comprehensive Loss | ||||||||
| Balance at July 1, 2024 | | $(413) | | $(167) | | $(1,458) | | $(2,038) |
| Other comprehensive loss before reclassifications, net of taxes | | - | | 198 | | 245 | | 443 |
| Total other comprehensive income (loss) before reclassifications, net of taxes | | (413) | | 31 | | (1,213) | | (1,595) |
| Net amount reclassified to earnings | | (1) | | 23 | | - | | 22 |
| Balance at September 30, 2024 | | $(414) | | $54 | | $(1,213) | | $(1,573) |
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · · · · Foreign Currency · | ||||||||
| · Pension Liability · Fair Value of · Translation · Accumulated Other | ||||||||
| · Adjustment · Derivatives · Adjustment · Comprehensive Loss | ||||||||
| Balance at January 1, 2024 | | $(412) | | $41 | | $(1,250) | | $(1,621) |
| Other comprehensive income (loss) before reclassifications, net of taxes | | - | | (8) | | 37 | | 29 |
| Total other comprehensive income (loss) before reclassifications, net of taxes | | (412) | | 33 | | (1,213) | | (1,592) |
| Net amount reclassified to earnings | | (2) | | 21 | | - | | 19 |
| Balance at September 30, 2024 | | $(414) | | $54 | | $(1,213) | | $(1,573) |
Taxes related to each component of other comprehensive loss were not material for each of the three and nine-month periods presented and therefore not disclosed separately.
All reclassifications from accumulated other comprehensive income (loss) had an impact on direct operating costs in the condensed consolidated statements of operations and comprehensive income.
**10.**Segment reporting and concentrations
The Company’s operations are classified inthree reporting segments: Digital Data Solutions (“DDS”), Synodex and Agility.
The DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. The DDS segment also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
The Synodex segment provides an industry platform that transforms medical records into useable digital data organized in accordance with its proprietary data models or customer data models.
The Agility segment provides an industry platform that provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news channels (print, web, radio and TV) and social media channels.
A significant portion of the Company’s revenues is generated from its locations in the Philippines, India, Sri Lanka, Canada, Germany, Israel, United States and the United Kingdom.
The Company’s chief operating decision maker (“CODM”) is the senior executive committee that includes the chief executive officer, the chief operating officer, and the chief financial officer (interim).
The U.S. GAAP measures used by the Company’s CODM to evaluate segment performance and allocate resources—such as employees, property, and financial or capital resources during the annual budgeting and forecasting process, are Revenues, Gross Profit and Income before provision for income taxes. Performance results are monitored, reviewed, and measured monthly and quarterly by comparing budget and forecast to actual results for profit measures, assessing returns on investment, compensation decisions and changing strategies, if required.
The accounting policies used by the DDS, Synodex and Agility segments are the same as those described in the summary of significant accounting policies.
The measure of segment assets is reported on the balance sheet as total consolidated assets shown in the table below (in thousands):
| · · · · · · | ||||
|---|---|---|---|---|
| · September 30, 2025 · December 31, 2024* | ||||
| Total assets: · · | ||||
| DDS | | $133,505 | | $91,588 |
| Synodex | | 5,139 | | 4,790 |
| Agility(1) | | 14,272 | | 17,071 |
| Total Consolidated | | $152,916 | | $113,449 |
*Prior period segment assets of DDS, Synodex and Agility segments have been reclassified to align with the current period presentation, with no impact on the Company’s consolidated results.
| (1) | Agility assets include goodwill of $2.1 million and $2.0 million for each of the periods ended September 30, 2025 and December 31, 2024, respectively. |
| (2) | Segment assets consist of cash, receivables, prepaid and other assets, property and equipment, right of-use-assets, deferred income tax and intangibles. |
The table below shows segment information for other significant income statement items (in thousands):
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Three Months Ended September 30, 2025 | ||||||||||||
| · · DDS · · · Synodex · Agility · Total | ||||||||||||
| Revenues | $54,779 | $1,653 | | $6,118 | | $62,550 | ||||||
| Direct operating costs (1) (3) | | | 32,627 | | | 1,536 | | | 2,883 | | | 37,046 |
| Gross profit | | 22,152 | | 117 | | | 3,235 | | | 25,504 | ||
| Selling and administrative expenses (2) (4) | | 10,246 | | 161 | | | 3,338 | | | 13,745 | ||
| Segment operating income (loss) | | | 11,906 | | | (44) | | | (103) | | | 11,759 |
| Interest income, net | | (420) | | - | | | - | | | (420) | ||
| Income (loss) before provision for income taxes | | $12,326 | | $(44) | | $(103) | | $12,179 | ||||
| · · · · · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| · · Three Months Ended September 30, 2024 | ||||||
| · DDS · · Synodex · · Agility · · Total | ||||||
| Revenues | | $44,694 | $1,935 | $5,595 | $52,224 | |
| Direct operating costs (1) (3) | | 27,084 | | 1,452 | 2,357 | 30,893 |
| Gross profit | | 17,610 | | 483 | 3,238 | 21,331 |
| Selling and administrative expenses (2) (4) | | 6,996 | | 102 | 2,812 | 9,910 |
| Segment operating income | | 10,614 | | 381 | 426 | 11,421 |
| Interest (income) expense, net | | (27) | | - | 1 | (26) |
| Income before provision for income taxes | | $10,641 | | $381 | $425 | $11,447 |
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | Nine Months Ended September 30, 2025 | |||||||||||
| · · DDS · Synodex · Agility · Total | ||||||||||||
| Revenues | $156,186 | $5,731 | | $17,370 | | $179,287 | ||||||
| Direct operating costs (1) (3) | | | 94,905 | | | 4,615 | | | 7,988 | | | 107,508 |
| Gross profit | | | 61,281 | | | 1,116 | | | 9,382 | | | 71,779 |
| Selling and administrative expenses (2) (4) | | | 32,275 | | | 587 | | | 9,975 | | | 42,837 |
| Segment operating income (loss) | | | 29,006 | | | 529 | | | (593) | | | 28,942 |
| Interest (income) expense, net | | | (1,125) | | | - | | | 1 | | | (1,124) |
| Income (loss) before provision for income taxes | | $30,131 | | $529 | | $(594) | | $30,066 | ||||
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Nine Months Ended September 30, 2024 | ||||||||
| | | DDS | | Synodex | | Agility | | Total |
| Revenues | $89,810 | $5,792 | $15,679 | $111,281 | ||||
| Direct operating costs (1) (3) | | 59,563 | | 4,454 | | 6,947 | | 70,964 |
| Gross profit | | 30,247 | | 1,338 | | 8,732 | | 40,317 |
| Selling and administrative expenses (2) (4) | | 18,988 | | 365 | | 7,882 | | 27,235 |
| Segment operating income | | 11,259 | | 973 | | 850 | | 13,082 |
| Interest (income) expense, net | | (58) | | - | | 3 | | (55) |
| Income before provision for income taxes | | $11,317 | | $973 | | $847 | | $13,137 |
| (1) | Direct operating costs consist of direct and indirect labor costs, occupancy costs, data center hosting fees, cloud services, content acquisition costs, depreciation and amortization, travel, telecommunications, computer services and supplies, realized (gain) loss on forward contracts, foreign currency revaluation (gain) loss, recruitment costs and other direct expenses that are incurred in providing services to our customers. |
| (2) | Selling and administrative expenses consist of payroll and related costs including commissions, bonuses, and stock-based compensation; marketing, advertising, trade conferences and related expenses; new services research and related software development expenses, software and cloud service subscriptions, professional and consultant fees, provision for credit losses and other administrative overhead expenses. |
| (3) | Includes non-cash expenses which consist mainly of depreciation, amortization of capitalized software development costs and stock-based compensation expense. |
| (4) | Includes non-cash expenses which consist mainly of stock-based compensation expense. |
Revenues for the threeand nine-month periods ended September 30, 2025, and 2024 by geographic region (determined based upon customer’s domicile), were as follows (in thousands):
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · For the Three Months Ended · · For the Nine Months Ended | ||||||||||||
| · · September 30, · · September 30, | ||||||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||||||
| United States | | $52,752 | | $43,237 | | $150,202 | | $84,910 | ||||
| Canada | | 3,024 | | 2,281 | | 8,702 | | 6,791 | ||||
| United Kingdom | | 2,735 | | 2,586 | | 7,635 | | 7,200 | ||||
| The Netherlands | | | 1,864 | | | 1,880 | | | 6,320 | | | 5,924 |
| Others - principally other European countries | | 2,175 | | 2,240 | | 6,428 | | 6,456 | ||||
| Totals | | $62,550 | | $52,224 | | $179,287 | | $111,281 | ||||
Long-lived assets as of September 30, 2025 and December 31, 2024 by geographic region were comprised of (in thousands):
| | | | | | | |
|---|---|---|---|---|---|---|
| · September 30, · December 31, | ||||||
| · 2025 · 2024 | ||||||
| United States | | $12,455 | | $10,182 | ||
| | | | | | ||
| Foreign countries: | | | | | ||
| Canada | | 6,247 | | 6,265 | ||
| United Kingdom | | 707 | | 806 | ||
| Philippines | | 4,500 | | 3,532 | ||
| India | | 2,637 | | 2,251 | ||
| Sri Lanka | | 817 | | 587 | ||
| Israel | | 60 | | 63 | ||
| Germany | | | 4 | | | 4 |
| Total foreign | | 14,972 | | 13,508 | ||
| Totals | | $27,427 | | $23,690 | ||
Long-lived assets include the unamortized balance of right-of-use assets amounting to $4.3 million and $4.2 million as of September 30, 2025 and December 31, 2024, respectively.
One customer in the DDS segment generated approximately 56% and 59% of the Company’s total revenues for the three months ended September 30, 2025 and 2024, respectively. No other customer accounted for 10% or more of total revenues during these periods. Further, revenues from non-U.S. customers accounted for 16% and 17% of the Company’s total revenues for the three months ended September 30, 2025 and 2024, respectively.
One customer in the DDS segment generated approximately 58% and 44% of the Company’s total revenues for the nine months ended September 30, 2025 and 2024, respectively. No other customer accounted for 10% or more of total revenues during these periods. Further, revenues from non-U.S. customers accounted for 16% and 24% of the Company’s total revenues for the nine months ended September 30, 2025 and 2024, respectively.
As of September 30, 2025, approximately 10% of the Company’s accounts receivable was due from foreign (principally European) customers and 58% of the Company’s accounts receivable was due fromone customer. As of December 31, 2024, approximately 16% of the Company’s accounts receivable was due from foreign (principally European) customers and 61% of the Company’s accounts receivable was due fromtwo customers. No other customer accounted for 10% or more of the accounts receivable as of September 30, 2025 and December 31, 2024.
**11.**Income Per Share
The calculation of the dilutive effect of outstanding options is shown in the table below (in thousands):
| · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · For the Three Months Ended · · For the Nine Months Ended | ||||||||
| · · September 30, · · September 30, | ||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||
| Net income attributable to Innodata Inc. and Subsidiaries | | $8,342 | | $17,389 | | $23,348 | | $18,364 |
| Weighted average common shares outstanding | | 31,848 | | 28,994 | | 31,690 | | 28,873 |
| Dilutive effect of outstanding options | | 3,418 | | 5,013 | | 3,306 | | 4,424 |
| Adjusted for dilutive computation | | 35,266 | | 34,007 | | 34,996 | | 33,297 |
Basic income per share is computed using the weighted-average number of common shares outstanding during the year. Diluted income per share is computed by considering the impact of the potential issuance of common shares, using the treasury stock method, on the weighted-average number of shares outstanding. For those securities that are not convertible into a class of common stock, the “two-class” method of computing income per share is used.
Options to purchase 3.6 million shares of common stock for the three months and nine months ended September 30, 2025 were outstanding and included in the computation of diluted income per share. Also included in the computation of diluted income per share for the three months and nine months ended September 30, 2025 are 390,569 restricted stock units using the treasury stock method to determine the dilutive effect of restricted stock units outstanding as of September 30, 2025.
Options to purchase 6.0 million shares of common stock for the three months and nine months ended September 30, 2024 were outstanding and included in the computation of diluted income per share. Also included in the computation of diluted income per share for the three months and nine months ended September 30, 2024 are 199,907 restricted stock units using the treasury stock method to determine the dilutive effect of restricted stock units outstanding as of September 30, 2024.
**12.**Derivatives
The Company conducts a large portion of its operations in international markets, which subjects it to foreign currency fluctuations. The most significant foreign currency exposures occur when revenue and associated accounts receivable are collected in one currency and expenses to generate that revenue are incurred in another currency. The Company is also subject to wage inflation and other government mandated increases and operating expenses in Asian countries where the Company has the majority of its operations. The Company’s primary inflation and exchange rate exposure relates to payroll, other payroll costs and operating expenses in the Philippines, India, Sri Lanka, Canada and Israel.
In addition, although most of the Company’s revenue is denominated in U.S. dollars, a portion of total revenues is denominated in Canadian dollars, Pound Sterling and Euros.
The Company’s policy is to enter derivative instrument contracts with terms that coincide with the underlying exposure being hedged for a period of up to 12 months. As such, the Company’s derivative instruments are expected to be highly effective. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded to other comprehensive income (loss). Upon settlement of these contracts, the change in the fair value recorded in other comprehensive income (loss) is reclassified to earnings and included as part of direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of direct operating costs.
The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking hedge transactions. The Company does not hold or issue derivatives for trading purposes. All derivatives are recognized at their fair value and classified based on the instrument’s maturity date. The total notional amount for outstanding derivatives designated as hedges was $13.2 million and $22.5 million as of September 30, 2025 and December 31, 2024, respectively.
The following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024 (in thousands):
| · · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Balance Sheet Location · · Fair Value | |||||
| · · · · September 30, · · December 31, | |||||
| · · 2025 · 2024 | |||||
| Derivatives designated as hedging instruments: · · | |||||
| · · · · · · · · | |||||
| Foreign currency forward contracts | Accrued expenses | | $238 | | $499 |
The effect of foreign currency forward contracts designated as cash flow hedges on the condensed consolidated statements of operations for the three and nine months ended September 30, 2025 and 2024 were as follows (in thousands):
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · For the Three Months Ended · · For the Nine Months Ended | ||||||||||||
| · September 30, · · September 30, | ||||||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||||||
| Net gain (loss) recognized in OCI(1) | | $(378) | | $198 | | $8 | | $(8) | ||||
| Net loss reclassified from accumulated OCI into income(2) | | $63 | | $23 | | $199 | | $21 | ||||
| Net gain recognized in income(3) | | $ | - | | $ | - | | $ | - | | $ | - |
(1)Net change in fair value of the effective portion classified into other comprehensive income (“OCI”).
(2)Effective portion classified within direct operating costs.
(3)There were no ineffective portions for the periods presented.
**13.**Line of Credit
On April 4, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, and Innodata Inc., Innodata Synodex, LLC, Innodata docGenix, LLC and Agility PR Solutions LLC as co-borrowers. On July 21, 2023, Innodata Services, LLC signed a Joinder Agreement to join the Credit Agreement as a co-borrower. On August 5, 2024, the Company entered into a second amendment to the Credit Agreement (together with the Credit Agreement, the “Amended Credit Agreement”). The Amended Credit Agreement provides for a secured revolving line of credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and$30.0 million (the “Maximum Credit”) and provides that a Borrower may request an increase to the Revolving Credit Facility’s Maximum Credit of up to, but not to exceed$50.0 million, subject to the approval of the Lender. The Revolving Credit Facility’s borrowing base is calculated on the basis of (i)85% of eligible accounts (other than eligible foreign accounts and unbilled accounts), plus (ii) the lesser of (a)80% of eligible accounts that are unbilled accounts and (b)30% of all eligible accounts, plus (iii) the lesser of (a)85% of eligible foreign accounts, (b)20% of all eligible accounts and (c)$4.0 million, minus (iv) certain other reserves and adjustments. As of September 30, 2025, such borrowing base calculation equaled approximately$30.0 million. The Credit Agreement contains a financial covenant that requires the Borrowers, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00. Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to the daily simple secured overnight financing rate (“SOFR”) plus 2.25%. The Company did not utilize the Revolving Credit Facility during the nine months ended September 30, 2025 or during the subsequent period through the filing date of this Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.